Prof. Daniel Razansky earned his degrees in Electrical and Biomedical Engineering from the TechnionâIsrael Institute of Technology and was further trained in bio-imaging at the Harvard Medical School. Since 2007 he is the Director of the Lab for Optoacoustics at the Institute for Biological and Medical Imaging (IBMI), Helmholtz Center Munich and is also a Professor of Molecular Imaging Engineering at the Technical University of Munich. His research lies at the forefront of the rapidly evolving area of molecular imaging sciences. As opposed to traditional anatomical imaging approaches, this multidisciplinary field aims at early diagnosis and improved classification of tissue function and stage of disease with highly potent applications in areas such as neuroscience, cancer research, and cardiovascular diagnostics. The particular focus is on the development of novel biomedical imaging tools based on optoacoustics, diffuse optics, ultrasound, and multi-modality approaches in order to enable imaging with high spatial and temporal resolution on different scales, from organ to cell. He has published more than 80 peer-reviewed journal articles and holds 12 inventions in bio-imaging and bio-sensing disciplines. He has also delivered over 50 invited and plenary lectures worldwide and serves on a number of editorial boards of international journals and research council review boards. He is recipient of a number of prices and awards, among them the Biovaria spin-off Award, ERC starting grant, and has been selected on the "Young Elite: Top 40 scientists under 40" list by the Capital magazine in 2011 and 2012.